Pmq Inga 2.5 mg Tablet 10's
₹14.9*
MRP ₹16.5
10% off
₹14.5*
MRP ₹16.5
15% CB
₹2 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Pmq Inga 2.5 mg Tablet 10's belongs to the class 'anti-malarials' primarily used for the treatment of malaria. A disease caused by a plasmodium parasite, transmitted by the bite of infected mosquitoes. The severity of malaria varies based on the species of plasmodium. Symptoms are chills, fever and sweating, usually occurring a few weeks after being bitten. People travelling to areas where malaria is common typically take protective drugs before, during and after their trip.
Pmq Inga 2.5 mg Tablet 10's contains 'primaquine'. It works by increasing the levels of haeme in the blood, a substance toxic to the malarial parasite. This kills the parasite and stops the infection from spreading. In this way Pmq Inga 2.5 mg Tablet 10's used for the prevention of relapse of malaria caused by plasmodium vivax and Plasmodium ovale strains of the parasite.
Pmq Inga 2.5 mg Tablet 10's should be taken as prescribed by your doctor, preferably with a meal to avoid stomach upset and at fixed intervals every day for best results. The dose of Pmq Inga 2.5 mg Tablet 10's can vary depending upon your condition and the severity of the infection. It is recommended to complete medicine and take this medicine as prescribed by your doctor before visiting a malaria-prone area. The common side effects of Pmq Inga 2.5 mg Tablet 10's include rash, vomiting, headache, dizziness, hives, stomach pain, nausea, abdominal pain, itching, heartburn, gastrointestinal discomfort, upper abdominal pain. Everyone need not experience the above side effects. In case of any discomfort, stop the medicine and speak with your doctor.
Before starting Pmq Inga 2.5 mg Tablet 10's, please inform your doctor if you are allergic to Pmq Inga 2.5 mg Tablet 10's. Do not take Pmq Inga 2.5 mg Tablet 10's on your own. Pmq Inga 2.5 mg Tablet 10's is used in caution with Pregnant/breast-feeding mother. Pmq Inga 2.5 mg Tablet 10's is not recommended in patients with heart disease, liver, kidney problems and rheumatoid-arthritis.
Pmq Inga 2.5 mg Tablet 10's belongs to the class 'anti-malarials' primarily used for the treatment of malaria. Pmq Inga 2.5 mg Tablet 10's contains 'primaquine'. It works by increasing the levels of haeme in the blood, a substance toxic to the malarial parasite. This kills the parasite and stops the infection from spreading. In this way Pmq Inga 2.5 mg Tablet 10's used for the prevention of relapse of malaria caused by plasmodium vivax and Plasmodium ovale strains of the parasite. Pmq Inga 2.5 mg Tablet 10's can also be given in combination with clindamycin for the treatment of Pneumocystis carinii pneumonia (PCP).
Before starting Pmq Inga 2.5 mg Tablet 10's, please inform your doctor if you are allergic to Pmq Inga 2.5 mg Tablet 10's. Do not take Pmq Inga 2.5 mg Tablet 10's on your own. Pmq Inga 2.5 mg Tablet 10's is used in caution with Pregnant/breast-feeding mother. Pmq Inga 2.5 mg Tablet 10's is not recommended in patients of heart disease, liver, kidney problems and rheumatoid arthritis. Pmq Inga 2.5 mg Tablet 10's is not recommended in patients of diabetes. Pmq Inga 2.5 mg Tablet 10's is not recommended for use in acutely ill patients suffering from a systemic disease like rheumatoid arthritis and lupus erythematosus. There is a marked decrease in the number of granulocytes in such conditions. Pmq Inga 2.5 mg Tablet 10's is also not recommended for use if you are receiving a medication that can cause anaemia or suppression of the immune system by affecting bone marrow cells as a side effect. Medicine is not recommended for use if you are consuming Quinacrine or any other combination medicine containing quinacrine (anti-malarial drug). Patients should avoid pregnancy during treatment. It is recommended to take this medicine for the entire prescribed duration even when symptoms improve or resolve. Failure to do so might result in drug resistance. Sexually active women can take effective Contraceptive pills and men should use a condom during and 3months after stopping the treatment. Pmq Inga 2.5 mg Tablet 10's should be discontinued immediately when leukopenia (reduced white blood cells) occurs.
Drug-Drug Interaction: Pmq Inga 2.5 mg Tablet 10's can interact with pain killers (aspirin), antibiotics (ciprofloxacin), antimalarials (quinacrine), corticosteroids (dexamethasone), anti-epileptic (Phenytoin), vitamins (cyanocobalamin, cholecalciferol, riboflavin, pyridoxine, thiamine, ascorbic acid).
Drug-Food Interaction: Limit the consumption of grapefruit or grapefruit juice with Pmq Inga 2.5 mg Tablet 10's as it can significantly increase the level of this medicine in the blood.
Drug-Disease Interaction: People affected with eye disorder (oculotoxicity), blood disease (porphyria), heart disease (arrhythmias), bone marrow suppression, seizures, enzyme deficiency (G-6-PD deficiency), liver disease (hepatotoxicity), hemolytic anaemia should not take Pmq Inga 2.5 mg Tablet 10's without doctors consultation.
Malaria: It is a severe & fatal parasitic infection caused by a protozoan called Plasmodium. 4 types of parasites can infect humans with malaria: Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale, and Plasmodium malaria. Female anopheles mosquito bites cause it. If bitten by an infected mosquito (the Anopheles mosquito), malaria parasites are injected into the blood. These parasites then migrate to the liver where they multiply via the bloodstream. A patient doesn't feel sick at this period because the parasites are in the liver. Then the parasites leave the liver and enter the red blood cells where the parasites are developing and then the red blood cells burst, allowing them to transfer to another blood cell. The parasites release harmful chemicals into the bloodstream at this point and the patient begins to feel ill. Malaria leads to periodic fever-chills, anaemia, kidney failure and jaundice because of excessive red blood cell death due to plasmodium growth inside them.
Country of origin
Alcohol
Caution
Interaction of Pmq Inga 2.5 mg Tablet 10's with alcohol is unknown. It is advisable to consult your doctor before consumption.
Pregnancy
Caution
Pmq Inga 2.5 mg Tablet 10's is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations, if the benefits are more than the potential risks. Please consult your doctor.
Breast Feeding
Caution
Pmq Inga 2.5 mg Tablet 10's is recommended for use in breastfeeding women only after diagnostic tests are performed to confirm normal G6PD enzyme levels. Consult your doctor before using this medicine
Driving
Caution
Pmq Inga 2.5 mg Tablet 10's may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Liver
Caution
Pmq Inga 2.5 mg Tablet 10's therapy is unlikely to cause liver injury in normal individuals but can trigger an acute worsening of porphyria in rare cases. Thus doctor's consultation is recommended before taking Pmq Inga 2.5 mg Tablet 10's
Kidney
Caution
Pmq Inga 2.5 mg Tablet 10's administration impairs kidney function in a few cases, so a patient is recommended to consult a doctor before taking Pmq Inga 2.5 mg Tablet 10's.
Children
Caution
Safe to use in children (<12) yet dose adjustment by a doctor will be done on the basis of age, weight and severity of the infection.
Product Substitutes